European healthcare innovation is undergoing a period of significant transformation, driven by new technologies, international collaborations and increasingly open partnership models. Against this backdrop, HLTH Europe is the leading European event dedicated to healthcare innovation, at a time when the digital transformation of healthcare in Europe is accelerating new collaborations between institutions, businesses, start-ups and industry stakeholders.
We discuss this with Francisco Mejia, New Business Sales Manager at HLTH Europe, to explore the new opportunities in the European market, the value of partnerships and the role of international events in fostering innovation, networking and the development of new healthcare solutions.
From the transformative potential of artificial intelligence to the impact of the European Health Data Space, right through to the challenges associated with large-scale innovation and the building of effective partnerships, we analyse the factors currently shaping the European healthcare ecosystem and the direction in which it is heading.
HLTH brings together a broad cross-section of the European healthcare ecosystem. What are you seeing at HLTH Europe that tells you where the European digital health agenda is heading, and what are the key themes you expect to dominate the conversation at the next edition?
The EU agenda regarding healthcare is moving towards the patient as a central point of care. As it looks beautiful, it's full of challenges where Policymakers and technology providers need to ease the barriers and let individuals take control of their health data in an effective manner.
In this way, the topics that will dominate next year's edition will be AI, personalized healthcare, and robotics in health.
It is dominating the digital health agenda. Beyond the hype, where do you see AI having the greatest potential to transform healthcare in Europe over the next 3–5 years?
As a new technology, there will always be cycles from hype to adoption. I’d say that we just crossed the hype cycle, and we are seeing real-time integrations with AI, so the conversation has shifted from an idea to a reality, and now we can clearly say that AI is shaping the way we interact with the healthcare system. The conversations with AI now are about real use cases that are being deployed in primary care facilities, like voice transcription to the EMRs, or the AI detection algorithms in radiology.
In five (5) years we might be in a totally different scenario, and could be that AI will be still the backbone of the infrastructure of the digital health, but its quite possible than in 5 years another emerging technology might take the headlines, while AI will be enter into a phase where people is using without knowing as it happens now with the Internet or the clouds.
The European Health Data Space (EHDS) is set to reshape how health data is accessed, shared and used across Europe. From your perspective, what impact could the EHDS have on digital health innovation and on the way healthcare organisations and market players develop and scale new solutions?
The impact is massive, as it is a wide EU policy; this means that it is mandatory for all healthcare stakeholders to be compliant with the EHDS regulations. So the whole ecosystem (not only one part of it) needs to elevate its digitalization capabilities in a way that is interoperable, accessible, and shareable within the regulations.
By default, this will have some consequences:
- Healthcare will become a truly connected industry, like banking and insurance. That will help to provide more accurate and personalized care.
- It will present some accessibility barriers to technology providers outside of the EU.
- The development of the products could have longer approval cycles to go to market in the EU.
- In the next 3-5 years, we’ll see major investments from the EU, individual countries, and directly from the companies (vendors), which will make the full production cycle (from idea to market) more efficient.
- Only companies with a mid-term and long-term vision will be able to resist the challenges that the reality of the EHDS will bring in the next few years.
What are healthcare providers and health systems looking for today when they evaluate digital health solutions? And what role can technology companies and other implementation partners play in turning innovative technologies into solutions that can actually be integrated into healthcare systems?
The providers are looking for solutions that are: TESTED, TRUSTED, and SECURED, and that solve real day-to-day problems. Secondly, the technology can’t add unnecessary workload for the (already) tired healthcare professionals.
I call it the TTS check. I don’t think a big university hospital or an NHS facility will adopt a technology that fails any word on the test. That said, technology adoption needs to be done with frameworks and cycles, first with some testing, pilots, a small population, and then the full deployment.
The technology companies need to balance between the adoption of their systems and their initial profitability. Basically, if the tech companies wants a more rapid changes, they need to also have the load of the education of the health professionals at this cost, otherwise we could get into a situation where only few providers will be willing to invest in a technology in a long term vision, and as a consequence making the equity gaps even bigger than today where only the powerful regions will get access to the most up-to-date technology (which still happening now in EU).
For European digital health startups and scale-ups, what do you see as the biggest obstacle to moving from successful pilots to large-scale adoption? And how can partnerships between startups, healthcare organisations, technology providers and other market players help overcome this gap?
There are two palpable issues especially for those two groups:
Slow paced deals in EU
- EU startups being founded by US investors;
- They are quite tied together and will explain why.
The deals in the healthcare industry in the EU are quite slow, the bureaucratic, legal systems and even languages make the pace of the deals ridiculously slow in Europe, and often the healthcare providers are not willing to take any risk by hiring a startup solution, and sometimes still go for technologies brought from already established companies.
The biggest obstacle I’m seeing is in the way they are being founded. A lot of EU startups are getting their investors from the US market, which expects quick turnarounds, and put the startup in a situation where they existence will be at risk if they sign contracts with the providers, but the company is not mature enough to get those contracts. That said, the partnership will have the power to leverage this situation if it works in a win-win situation for all parties involved. Also Startups need to be more wise with their capital. Cash is limited especially for them.
Looking ahead five years, what would you like to see Europe having achieved in digital health - and what needs to happen today to get there?
I do see that in 5 years the EHDS will be a normality and even patients will fully understand what this is all about, therefore we (patients) will have access to their health data in a way that we can’t even think about today. You might be able to download ALL your health information in a PDF, even if part of the record was taken in your residence country or not!